Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in mice

Journal of Orthopaedic Research

Volumn 31, Issue 7, 2013, Pages 1075-1081

  Bivi, Nicoletta ^a   Pacheco Costa, Rafael ^a,b   Brun, Lucas R ^a   Murphy, Thomas R ^a   Farlow, Nathan R ^a   Robling, Alexander G ^a   Bellido, Teresita ^a,c   Plotkin, Lilian I ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

catenin; bone formation; connexin43; mechanical loading; osteocyte

Indexed keywords

BETA CATENIN; CX43 PROTEIN; PROTEIN; PROTEIN HYDROLYSATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE CELL; CELL CULTURE; CONTROLLED STUDY; IN VIVO STUDY; MECHANICAL STIMULATION; MECHANOTRANSDUCTION; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCYTE; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; CELL COMMUNICATION; CELLS, CULTURED; CONNEXIN 43; FEMALE; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; OSTEOBLASTS; OSTEOCYTES; OSTEOGENESIS; STRESS, MECHANICAL; ULNA; WNT PROTEINS;

EID: 84878204226     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22341     Document Type: Article

References (36)

1. Bonewald LF, Johnson ML., 2008. Osteocytes, mechanosensing and Wnt signaling. Bone 42: 606-615.
2. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, et al. 2006. WNT/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281: 31720-31728. (Pubitemid 46043263)
3. Tu X, Rhee Y, Condon KW, et al. 2012. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 50: 209-217.
4. Robling AG, Niziolek PJ, Baldridge LA, et al. 2008. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283: 5866-5875.
5. Glass DA, Bialek P, Ahn JD, et al. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751-764. (Pubitemid 40585297)
6. Holmen SL, Zylstra CR, Mukherjee A, et al. 2005. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280: 21162-21168. (Pubitemid 40805677)
7. Kramer I, Halleux C, Keller H, et al. 2010. Osteocyte Wnt/β-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 30: 3071-3085.
8. Chang M, Kramer I, Kneissel M., 2011. Sclerostin deficiency does not induce bone gain in mice lacking osteocyte ß-catenin. J Bone Miner Res 26: S13.
9. Javaheri B, Dallas M, Zhao H, et al. 2011. β-Catenin haploinsufficiency in osteocytes abolishes the osteogenic effect of mechanical loading in vivo. J Bone Miner Res 26: S24.
10. Lecanda F, Warlow PM, Sheikh S, et al. 2000. Cx43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151: 931-944.
11. Jiang JX, Cherian PP., 2003. Hemichannels formed by Cx43 play an important role in the release of PGE2 by osteocytes in response to mechanical strain. Cell Commun Adhes 10: 259-264. (Pubitemid 38081382)
12. Genetos DC, Kephart CJ, Zhang Y, et al. 2007. Oscillating fluid flow activation of gap junction hemichannels induces ATP release from MLO-Y4 osteocytes. J Cell Physiol 212: 207-214. (Pubitemid 46867603)
13. Siller-Jackson AJ, Burra S, Gu S, et al. 2008. Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading. J Biol Chem 283: 26374-26382.
14. Zhang Y, Paul EM, Sathyendra V, et al. 2011. Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. PLoS ONE 6: e23516.
15. Bivi N, Condon KW, Allen MR, et al. 2012. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J Bone Min Res 27: 374-389.
16. Alam I, Warden SJ, Robling AG, Turner CH., 2005. Mechanotransduction in bone does not require a functional cyclooxygenase-2 (COX-2) gene. J Bone Miner Res 20: 438-446. (Pubitemid 40293492)
17. Allen MR, Reinwald S, Burr DB., 2008. Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment. Calcif Tissue Int 82: 354-360.
18. Plotkin LI, Bivi N, Bellido T., 2011. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice. Bone 49: 122-127.
19. Hauge E, Mosekilde L, Melsen F., 1999. Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone 25: 389-395. (Pubitemid 29424231)
20. Dempster DW, Compston JE, Drezner MK, et al. 2013. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Min Res 28: 2-17.
21. Plotkin LI, Lezcano V, Thostenson J, et al. 2008. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res 23: 1712-1721.
22. Tu X, Joeng KS, Nakayama KI, et al. 2007. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell 12: 113-127. (Pubitemid 46002598)
23. Plotkin LI, Aguirre JI, Kousteni S, et al. 2005. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of ERK activation. J Biol Chem 280: 7317-7325. (Pubitemid 40341290)
24. -ΔΔCT method. Methods 25: 402-408. (Pubitemid 34164012)
25. Bellido T, Ali AA, Plotkin LI, et al. 2003. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278: 50259-50272. (Pubitemid 37548867)
26. Plotkin LI, Weinstein RS, Parfitt AM, et al. 1999. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104: 1363-1374.
27. Santos A, Bakker AD, Zandieh-Doulabi B, et al. 2009. Pulsating fluid flow modulates gene expression of proteins involved in Wnt signaling pathways in osteocytes. J Orthop Res 27: 1280-1287.
28. Santos A, Bakker AD, Zandieh-Doulabi B, et al. 2010. Early activation of the beta-catenin pathway in osteocytes is mediated by nitric oxide, phosphatidyl inositol-3 kinase/akt, and focal adhesion kinase. Biochem Biophys Res Commun 391: 364-369.
29. Xia X, Batra N, Shi Q, et al. 2010. PG promotion of osteocyte gap junction function through transcriptional regulation of Cx43 by GSK3-βcatenin signaling. Mol Cell Biol 30: 206-219.
30. Case N, Ma M, Sen B, et al. 2008. Beta-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem 283: 29196-29205.
31. Grimston SK, Watkins MP, Brodt MD, et al. 2012. Enhanced periosteal and endocortical responses to axial tibial compression loading in conditional connexin43 deficient mice. PLoS ONE 7: e44222.
32. Grimston SK, Brodt MD, Silva MJ, Civitelli R., 2008. Attenuated response to in vivo mechanical loading in mice with conditional osteoblast ablation of the Cx43 gene (Gja1). J Bone Min Res 23: 879-886. (Pubitemid 351768806)
33. Gortazar AR, Martin-Millan M, Bravo B, et al. 2013. Crosstalk between caveolin-1/ERKs and ß-catenin survival pathways in osteocyte mechanotransduction. J Biol Chem doi: 10.1074/jbc.M112.437921.
34. Li MW, Mruk DD, Lee WM, et al. 2009. Cx43 and plakophilin-2 as a protein complex that regulates blood-testis barrier dynamics. Proc Natl Acad Sci U S A 106: 10213-10218.
35. Ai Z, Fischer A, Spray DC, et al. 2000. Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest 105: 161-171. (Pubitemid 30054355)
36. Talhouk RS, Mroue R, Mokalled M, et al. 2008. Heterocellular interaction enhances recruitment of alpha and beta-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependant differentiation of mammary epithelial cells. Exp Cell Res 314: 3275-3291.